Jonathan H. Talamo
Research Subjects
Research Interests
Jonathan H. Talamo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Claudia Cantu-Charles
Hospital San Jose de Monterrey-ITESM, Monterrey, Mexico
1 shared publication- Edward C. Parsons
CXL Ophthalmics, LLC, Encinitas, CA, USA
1 shared publication - George Alexandrakis
Coastal Marine Research Laboratory (CMRL), Institute of Applied and Computational Mathematics (IACM), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece
1 shared publication Glenwood G Gum
Absorption Systems California, LLC, San Diego, CA, USA
1 shared publicationIrwin M. Siegel
Department of Ophthalmology, New York University, New York
1 shared publication- J. Young
Analysis Group- Inc., Data Analytics, Boston, United States
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 15, 1985-1994
The Effect of Sodium Iodide on Stromal Loading, Distribution and Degradation of Riboflavin in a Rabbit Model of Transepithelial Corneal Crosslinking
Purpose: To evaluate effects of sodium iodide (NaI) on riboflavin concentration in corneal stroma before and during ultraviolet A (UVA) light exposure using a novel transepithelial corneal collagen crosslinking (CXL) procedure (EpiSmart CXL system, CXL Ophthalmics, Encinitas CA). Methods: Riboflavin solutions with NaI (Ribostat, CXL Ophthalmics, Encinitas CA) and without NaI were used for CXL in rabbits using EpiSmart. A pilot study determined sufficient riboflavin loading time. Four rabbits were dosed and monitored. Riboflavin fluorescence intensity was assessed from masked slit-lamp photos. A 12 min loading time was selected. Sixteen additional rabbits received the two formulae in contralateral eyes for CXL. Riboflavin uptake was assessed at 0, 10, 15, 20, 25, and 30 min of UVA exposure using a scale for riboflavin fluorescence previously validated against stromal concentration. Post sacrifice, corneal stromal samples were analyzed for concentrations of riboflavin and riboflavin 5'-phosphate. Results: Eyes dosed with NaI riboflavin had higher riboflavin grades compared to eyes dosed with the NaI-free riboflavin formulation immediately after riboflavin loading and persisting throughout UVA exposure, with significantly higher (P < 0.01 to < 0.05) riboflavin grades from 15 through 25 min of UVA exposure. Riboflavin grades decreased more slowly in eyes dosed with NaI riboflavin through 25 minutes of UVA exposure. Minor conjunctival irritation was noted with or without NaI. Conclusion: The addition of NaI to riboflavin solution is associated with increased riboflavin concentration in corneal stroma throughout a clinically relevant time course of UVA exposure. This effect may be a combination of enhanced epithelial penetration and reduced riboflavin photodegradation and should enhance intrastromal crosslinking.
- 1 January 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 15, 1985-1994
Open AccessThe Effect of Sodium Iodide on Stromal Loading, Distribution and Degradation of Riboflavin in a Rabbit Model of Transepithelial Corneal Crosslinking
Purpose: To evaluate effects of sodium iodide (NaI) on riboflavin concentration in corneal stroma before and during ultraviolet A (UVA) light exposure using a novel transepithelial corneal collagen crosslinking (CXL) procedure (EpiSmart CXL system, CXL Ophthalmics, Encinitas CA). Methods: Riboflavin solutions with NaI (Ribostat, CXL Ophthalmics, Encinitas CA) and without NaI were used for CXL in rabbits using EpiSmart. A pilot study determined sufficient riboflavin loading time. Four rabbits were dosed and monitored. Riboflavin fluorescence intensity was assessed from masked slit-lamp photos. A 12 min loading time was selected. Sixteen additional rabbits received the two formulae in contralateral eyes for CXL. Riboflavin uptake was assessed at 0, 10, 15, 20, 25, and 30 min of UVA exposure using a scale for riboflavin fluorescence previously validated against stromal concentration. Post sacrifice, corneal stromal samples were analyzed for concentrations of riboflavin and riboflavin 5'-phosphate. Results: Eyes dosed with NaI riboflavin had higher riboflavin grades compared to eyes dosed with the NaI-free riboflavin formulation immediately after riboflavin loading and persisting throughout UVA exposure, with significantly higher (P < 0.01 to < 0.05) riboflavin grades from 15 through 25 min of UVA exposure. Riboflavin grades decreased more slowly in eyes dosed with NaI riboflavin through 25 minutes of UVA exposure. Minor conjunctival irritation was noted with or without NaI. Conclusion: The addition of NaI to riboflavin solution is associated with increased riboflavin concentration in corneal stroma throughout a clinically relevant time course of UVA exposure. This effect may be a combination of enhanced epithelial penetration and reduced riboflavin photodegradation and should enhance intrastromal crosslinking.
- 1 October 1996
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 22 (8) , 1052-1061
Excimer photorefractive keratectomy for low myopia and astigmatism with the Coherent-Schwind Keratom
Purpose: To summarize the initial results of excimer laser photorefractive keratectomy (PRK) in 114 eyes of 89 patients using the Coherent-Schwind system and assess its safety, efficacy, and predictability. Setting: Hospital San Jose de Monterrey-ITESM, Mexico. Methods: The Coherent-Schwind Keratom excimer laser was used to correct low myopia (manifest spherical equivalent from −1.00 to −6.00 diopters [D], with manifest cylinder of −1.00 D or less) or myopic astigmatism (manifest spherical equivalent from −2.75 to −6.75 D, with manifest cylinder from −1.00 to −4.50 D) with standard settings. Ablation zone diameters were from 5.9 to 6.3 mm (low myopia) and 5.9 to 8.2 mm (astigmatism) with a repetition rate of 12 Hz. Follow-up was from 1 month (low myopia, n = 71; astigmatism, n = 35) to 6 months (low myopia, n = 36; astigmatism, n = 17). Results: Six months after PRK, uncorrected visual acuity was 20/40 or better in 94% of the low myopia eyes (n = 36) and 77% of the astigmatism eyes (n = 17). Intended correction was within 1.00 D of the target spherical equivalent in 81 and 88% of eyes, respectively. No eyes in the low myopia group lost two lines of best corrected visual acuity, although 12% in the astigmatism group did. Conclusion: The Coherent-Schwind excimer laser appears to be effective in the treatment of low myopia and astigmatism, with results comparable to those of other laser systems after 6 months of follow-up. Further study of best corrected visual acuity loss after treatment of compound myopic astigmatism with this laser is warranted.
- 1 October 1996
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 22 (8) , 1052-1061
Excimer photorefractive keratectomy for low myopia and astigmatism with the Coherent-Schwind Keratom
Purpose: To summarize the initial results of excimer laser photorefractive keratectomy (PRK) in 114 eyes of 89 patients using the Coherent-Schwind system and assess its safety, efficacy, and predictability. Setting: Hospital San Jose de Monterrey-ITESM, Mexico. Methods: The Coherent-Schwind Keratom excimer laser was used to correct low myopia (manifest spherical equivalent from −1.00 to −6.00 diopters [D], with manifest cylinder of −1.00 D or less) or myopic astigmatism (manifest spherical equivalent from −2.75 to −6.75 D, with manifest cylinder from −1.00 to −4.50 D) with standard settings. Ablation zone diameters were from 5.9 to 6.3 mm (low myopia) and 5.9 to 8.2 mm (astigmatism) with a repetition rate of 12 Hz. Follow-up was from 1 month (low myopia, n = 71; astigmatism, n = 35) to 6 months (low myopia, n = 36; astigmatism, n = 17). Results: Six months after PRK, uncorrected visual acuity was 20/40 or better in 94% of the low myopia eyes (n = 36) and 77% of the astigmatism eyes (n = 17). Intended correction was within 1.00 D of the target spherical equivalent in 81 and 88% of eyes, respectively. No eyes in the low myopia group lost two lines of best corrected visual acuity, although 12% in the astigmatism group did. Conclusion: The Coherent-Schwind excimer laser appears to be effective in the treatment of low myopia and astigmatism, with results comparable to those of other laser systems after 6 months of follow-up. Further study of best corrected visual acuity loss after treatment of compound myopic astigmatism with this laser is warranted.
- 1 July 1995
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 21 (4) , 404-406
Contour resolution of the EyeSys Corneal Analysis System
We investigated the accuracy of a conventional videokeratography instrument (Corneal Analysis System, EyeSys Laboratories) to measure contour information using specialized software developed by the manufacturer. Seven calibrated spheres were measured and the results tabulated. A contour resolution for all spheres for all reflected rings was found to be ±0.0047 mm, representing a 95% confidence interval. This level of resolution is high enough to obtain clinical value from using the EyeSys instrument as a contour measuring device.
- 1 July 1995
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 21 (4) , 404-406
Contour resolution of the EyeSys Corneal Analysis System
We investigated the accuracy of a conventional videokeratography instrument (Corneal Analysis System, EyeSys Laboratories) to measure contour information using specialized software developed by the manufacturer. Seven calibrated spheres were measured and the results tabulated. A contour resolution for all spheres for all reflected rings was found to be ±0.0047 mm, representing a 95% confidence interval. This level of resolution is high enough to obtain clinical value from using the EyeSys instrument as a contour measuring device.